Hi Dolc,
It seems Ive upset you by raising the issue but Ive had 3 previous Biotechs that we all thought at the time were tight as a drum and they all fell. Iam not complaining, collectively I made a few million but Iam still telling you if J&J or Merck want MSB it would be a hard fend off.
Personally Iam all for MSB to go it alone but its a jungle out there and sometimes companies get eaten.
I dont like the crossing action of late from my experience that was a hall mark of what I just described .
Aloha.
Analysis of the EAP, page-431
-
- There are more pages in this discussion • 640 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |